Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Jul 23, 2026
Date Accepted: Nov 2, 2026

The final, peer-reviewed published version of this preprint can be found here:

Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey

Zhang R, Wu Y, Ren Z, Huang L, Zhao Y, Zheng X, Qian J, Wang Y

Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey

JMIR Public Health Surveill 2026;12:e107757

DOI: 10.2196/107757

Infectious disease diagnostic capacity across hospital tiers in China: a national cross-sectional survey

  • Ruyi Zhang; 
  • Yu Wu; 
  • Ziyang Ren; 
  • Lieyu Huang; 
  • Yihao Zhao; 
  • Xiaoying Zheng; 
  • Jie Qian; 
  • Yajie Wang

ABSTRACT

Background:

China has maintained a national notifiable infectious disease reporting system since the 1950s and introduced nationwide web-based direct reporting in 2004. The system supports monitoring of incidence, mortality, temporal and geographic trends, and outbreaks. However, reported case counts depend on clinical recognition, diagnostic testing, and confirmation. Uneven hospital diagnostic capacity may therefore contribute to differential case ascertainment and complicate interpretation of surveillance-based disease burden.

Objective:

The objective of this study was to characterize infectious disease diagnostic capacity across hospital tiers in China and assess burden–capacity alignment, regional variation, modality-specific capacity, and implementation barriers, thereby identifying potential structural sources of differential case ascertainment and informing interpretation of surveillance data and future diagnostic-network planning.

Methods:

We conducted a national cross-sectional web-based survey of hospitals in China in 2023. After centralized quality control and eligibility screening, 2689 hospitals were included: 124 primary, 1478 secondary, and 1087 tertiary hospitals. We assessed in-house and send-out testing, hospital-level coverage of statutory notifiable infectious diseases, national burden–capacity patterns, regional variation, modality-specific capacity for four tracer diseases, and reported barriers.

Results:

Median in-house diagnostic coverage increased from 11.6% in primary hospitals to 27.9% in secondary hospitals and 39.5% in tertiary hospitals; corresponding overall coverage including send-out testing was 14%, 32.6%, and 41.9%. Four burden–capacity patterns emerged. Program-prioritized infections were relatively well supported, with in-house hepatitis B testing available in more than 80% of hospitals at every tier. Pulmonary tuberculosis showed a pronounced tier gradient, increasing from 21% in primary hospitals to 83.7% in tertiary hospitals. High-incidence community-transmitted infections remained under-supported even in tertiary hospitals, including hand, foot and mouth disease (35%) and other infectious diarrheal diseases (42%). Lower-incidence but high-consequence infections also had limited local capacity, including hemorrhagic fever with renal syndrome (13.9%), rabies (4%), and Japanese encephalitis (4.3%) in tertiary hospitals. Regionally, pulmonary tuberculosis testing was more frequent in central and western primary and secondary hospitals, whereas hemorrhagic fever with renal syndrome testing was concentrated in northeastern secondary and tertiary hospitals. HBV DNA testing increased from 8.1% in primary hospitals to 61.1% in tertiary hospitals, whereas method-specific testing for hand, foot and mouth disease remained limited. Lower-tier hospitals more often reported infrastructure, workforce, technical, and biosafety constraints, whereas tertiary hospitals more often reported reagent-licensing and fee-schedule barriers.

Conclusions:

Infectious disease diagnostic capacity in China was strongly stratified by hospital tier, varied geographically, and was only partly aligned with disease burden. These differences may contribute to differential case ascertainment in routine surveillance. Tiered and regionally responsive diagnostic networks are needed to strengthen case detection. The findings also provide an empirical basis for more valid interpretation and future calibration of surveillance-based disease burden. Clinical Trial: NA


 Citation

Please cite as:

Zhang R, Wu Y, Ren Z, Huang L, Zhao Y, Zheng X, Qian J, Wang Y

Infectious Disease Diagnostic Capacity Across Hospital Tiers in China: National Cross-Sectional Survey

JMIR Public Health Surveill 2026;12:e107757

DOI: 10.2196/107757

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.